Contact Us Site Map

Our Research and Development

PRAECIS has a dedicated research and development organization focused on the discovery and development of novel compounds with the potential to address unmet medical needs or improve existing therapies.

One of our programs has moved beyond the research phase and into clinical testing:

In addition, we have research programs focused on developing therapies to treat certain autoimmune diseases, certain types of cancer and other diseases.

The information about our product candidates includes assumptions about their effectiveness. These assumptions are based on theoretical scientific observations gleaned during various phases of pre-clinical and clinical development. With the exception of Plenaxis®, none of the drugs being developed by PRAECIS have received FDA (or other regulatory agency) approval for any of the potential indications discussed within this site.